** Medical device maker ResMed's RMD.N shares rise 8.1% to $231.81
** RMD posted late on Wednesday Q1 adj. profit of $2.37 per share, beating analysts' estimates of $2.36 per share, according to data compiled by LSEG
** Company's Q1 revenue rose 8% to $1.29 billion
** ResMed said it is "very well positioned" and does not expect the introduction of U.S. tariffs to have a material impact on its financial results
** Brokerage William Blair says ResMed products are also exempt from the announced April tariffs, making it "one of the safer stories, if not the safest, from recent headlines"
** "We are decreasing our forward EPS estimates modestly, given a challenging macro environment" - Jefferies
** As of last close, RMD has risen 1.3% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。